Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Clinical trial NCT01606982 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01606982
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.